Shigeaki Suzuki

H. Monyer, S. Schwab, A. Schneider, 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Necklace cytoplasmic bodies in hereditary myopathy with early respiratory failure

J. Kira, I. Nonaka, Y. Hayashi, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Transient receptor potential vanilloid 1-immunoreactive signals in murine enteric glial cells

Shigeaki Suzuki, N. Suzuki, J. Nakahara, 2016, World journal of gastroenterology.

Postischemic Hyperperfusion Does Not Necessarily Indicate Good Recovery of Brain Tissue. From the Viewpoint of PKA-Mediated Intracellular Signal Transduction

E. Nagata, Kortaro Tanaka, Y. Fukuuchi, 2001 .

Altered levels of serotonin in lymphoblasts derived from migraine patients

E. Nagata, M. Shibata, J. Hamada, 2007, Neuroscience Research.

[Immune checkpoint inhibitor-induced anti-striational antibodies in myasthenia gravis and myositis: a case report].

Shigeaki Suzuki, A. Watanabe, J. Kobayashi, 2021, Rinsho shinkeigaku = Clinical neurology.

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia

Shigeaki Suzuki, M. Jinnin, S. Fukushima, 2018, Annals of clinical and translational neurology.

Alteration of Control Mechanisms of Endoplasmic Reticulum Calcium Pools in Focal Cerebral Ischemia

A. Futatsugi, E. Nagata, D. Ito, 1999 .

Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies

I. Nishino, Shigeaki Suzuki, T. Komori, 2018, Neuromuscular Disorders.

Phosphorylation of Signal Transducer and Activator of Transcription-3 (Stat3) after Focal Cerebral Ischemia in Rats

Kortaro Tanaka, Y. Fukuuchi, A. Kosakai, 2001, Experimental Neurology.

Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons

H. Okano, K. Sawamoto, T. Kawase, 2005, Journal of neurochemistry.

A unique case of polymyositis with anti-signal recognition particle antibody complicated by subacute interstitial lung disease and subluxing arthropathy, resembling anti-synthetase syndrome

Shigeaki Suzuki, T. Takeuchi, M. Kuwana, 2016, Modern rheumatology.

A novel voltage-sensitive Na+ and Ca2+ channel blocker, NS-7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat

Kortaro Tanaka, Y. Fukuuchi, A. Kosakai, 2002, Brain Research.

Seeking ideal clinical guidelines for myasthenia gravis

Shigeaki Suzuki, M. Motomura, K. Utsugisawa, 2020 .

K. Fujihara, Shigeaki Suzuki, N. Suzuki, 2014, Muscle & nerve.

Anti-signal recognition particle myopathy in the first decade of life.

Y. Hayashi, I. Nishino, Shigeaki Suzuki, 2011, Pediatric neurology.

Clinical features and treatment status of adult myasthenia gravis in Japan

J. Kira, Shigeaki Suzuki, M. Motomura, 2014 .

Slow-progressive ataxia with a methionine-to-arginine point mutation in codon 232 in the prion protein gene (PRNP)

D. Ito, Shigeaki Suzuki, N. Suzuki, 2011, Clinical Neurology and Neurosurgery.

Sarcoplasmic MxA expression

I. Nishino, Shigeaki Suzuki, N. Suzuki, 2017, Neurology.

Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors

T. Kanai, Y. Hamamoto, Shigeaki Suzuki, 2020, Cancer management and research.

A case of myasthenia gravis and myositis induced by nivolumab.

Shigeaki Suzuki, H. Hoshino, M. Takagi, 2017, Rinsho shinkeigaku = Clinical neurology.

Overlooked non-motor symptoms in myasthenia gravis

Shigeaki Suzuki, N. Suzuki, K. Utsugisawa, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies

Shigeaki Suzuki, M. Seki, S. Kitano, 2021, Cancer Immunology, Immunotherapy.

Encephalitis as an immune-related adverse event

Shigeaki Suzuki, 2020, Journal of Neurology Neurosurgery & Psychiatry.

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin’s lymphoma

Shigeaki Suzuki, N. Suzuki, K. Mashima, 2015, International Journal of Hematology.

Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma

E. Kikuchi, M. Oya, Shigeaki Suzuki, 2020, International Cancer Conference Journal.

Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature

Shigeaki Suzuki, J. Nakahara, Kenichi Sakuta, 2020, Journal of Neurology.

Shigeaki Suzuki, N. Suzuki, Y. Hasegawa, 2017, Neurology.

Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patients.

I. Nishino, Shigeaki Suzuki, Y. Allenbach, 2020, Autoimmunity reviews.

APOLIPOPROTEIN E AND LONGEVITY: THE ROTTERDAM STUDY

Kortaro Tanaka, Y. Fukuuchi, Shigeaki Suzuki, 2001 .

[A case of Good syndrome accompanied by myasthenia gravis: immunological evaluations].

Kortaro Tanaka, S. Nogawa, Shigeaki Suzuki, 2006, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Immunodeficiency in patients with thymoma-associated myasthenia gravis

T. Shiina, Shigeaki Suzuki, J. Nakahara, 2022, Journal of Neuroimmunology.

Two-Year Treatment with Cyclosporine Microemulsion for Responder Myasthenia Gravis Patients

Shigeaki Suzuki, N. Suzuki, K. Utsugisawa, 2010, European Neurology.

Anti‐striational antibodies: Expanding their clinical significance

Shigeaki Suzuki, A. Uzawa, J. Nakahara, 2020 .

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis

Shigeaki Suzuki, Y. Ando, J. Nakahara, 2019, Scientific Reports.

Activation of NG2-Positive Oligodendrocyte Progenitor Cells after Focal Ischemia in Rat Brain

A. Kosakai, S. Nogawa, D. Ito, 2004 .

Activation and proliferation of oligodendrocyte progenitor cells after brain ischemia in the rat

Kortaro Tanaka, A. Kosakai, S. Nogawa, 2003 .

Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies

I. Nishino, W. Liang, Y. Jong, 2016, Rheumatology.

Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

R. Yamazaki, T. Nakazato, Y. Ikeda, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neurological aspects of mice heterozygous for type 1 inositol 1,4,5-trisphosphate receptor - electroencephalographic study

K. Mikoshiba, E. Nagata, Kortaro Tanaka, 1998, Neuroscience Research.

Diagnosis of dermatomyositis: Autoantibody profile and muscle pathology

I. Nishino, Shigeaki Suzuki, A. Uruha, 2017 .

Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.

I. Nishino, Shigeaki Suzuki, N. Suzuki, 2017, Autoimmunity reviews.

Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy

I. Nishino, Shigeaki Suzuki, N. Suzuki, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin

Shigeaki Suzuki, N. Suzuki, J. Nakahara, 2017, Medicine.

COX-2 expression in brains of patients with familial Alzheimer's disease

Kortaro Tanaka, Y. Fukuuchi, S. Nogawa, 2003 .

Identification of biomarkers associated with migraine with aura

E. Nagata, T. Tsunoda, M. Shibata, 2009, Neuroscience Research.

Marked Respiratory Failure in an Ambulant Patient with Immune-mediated Necrotizing Myopathy and Anti-Kv1.4 and Anti-titin Antibodies

I. Nishino, Shigeaki Suzuki, S. Kuwabara, 2021, Internal medicine.

Headache Associated with Myasthenia Gravis: The Impact of Mild Ocular Symptoms

M. Shibata, Shigeaki Suzuki, N. Suzuki, 2011, Autoimmune diseases.

A case of atypical inflammatory myositis with hypergammaglobulinemic purpura

Shigeaki Suzuki, N. Suzuki, M. Seki, 2016, Journal of the Neurological Sciences.

Inflammatory myopathies and human leukocyte antigen

T. Shiina, Shigeaki Suzuki, Y. Ohnuki, 2017 .

Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study

Shigeaki Suzuki, N. Suzuki, K. Utsugisawa, 2015, PloS one.

Immunohistochemical Phenotype of T Cells Invading Muscle in Inclusion Body Myositis.

Shigeaki Suzuki, T. Komori, S. Matsubara, 2022, Journal of neuropathology and experimental neurology.

Autoimmune targets of heart and skeletal muscles in myasthenia gravis.

Shigeaki Suzuki, N. Suzuki, M. Motomura, 2009, Archives of neurology.

[Recent concept of limbic encephalitis: progress in anti-NMDA receptor encephalitis].

Shigeaki Suzuki, N. Suzuki, M. Seki, 2013, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Autoreactive T cells to the P3A+ isoform of AChR α subunit in myasthenia gravis

Kortaro Tanaka, Y. Fukuuchi, Shigeaki Suzuki, 2003, Journal of Neuroimmunology.

Factors associated with response to calcineurin inhibitors in myasthenia gravis

Shigeaki Suzuki, N. Suzuki, K. Utsugisawa, 2010, Muscle & nerve.

Anemia in female patients with myasthenia gravis

Shigeaki Suzuki, J. Nakahara, T. Takizawa, 2022, PloS one.

[A case of systemic lupus erythematosus predominantly presenting with myositis at onset].

I. Nishino, Shigeaki Suzuki, M. Ikawa, 2013, Rinshō shinkeigaku Clinical neurology.

A Comparison of Line Blots, Enzyme-linked Immunosorbent, and RNA-immunoprecipitation Assays of Antisynthetase Antibodies in Serum Samples from 44 Patients

Shigeaki Suzuki, Koichiro Shinoda, H. Hounoki, 2022, Internal medicine.

Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002.

Kortaro Tanaka, S. Nogawa, Shigeaki Suzuki, 2005, Internal medicine.

T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris.

T. Nishikawa, Hayato Takahashi, Y. Ikeda, 2007, The Journal of investigative dermatology.

Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention

R. Yamazaki, Shigeaki Suzuki, J. Nakahara, 2019, Bone Marrow Transplantation.

Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis

R. Yamazaki, Jun Kato, Shigeaki Suzuki, 2017, International Journal of Hematology.

Pathologic Features of Anti-Mi-2 Dermatomyositis

N. Okiyama, M. Fujimoto, I. Nishino, 2020, Neurology.

Skeletal Muscle Involvement in Antisynthetase Syndrome

T. Shiina, I. Nishino, Shigeaki Suzuki, 2017, JAMA neurology.

Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.

Y. Hayashi, I. Nishino, Shigeaki Suzuki, 2012, Archives of neurology.

Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients

Y. Hayashi, I. Nishino, Shigeaki Suzuki, 2015, Orphanet Journal of Rare Diseases.

Reappraisal of Oral Steroid Therapy for Myasthenia Gravis

Shigeaki Suzuki, A. Uzawa, K. Utsugisawa, 2020, Frontiers in Neurology.

Differential diagnosis between intracranial dissemination of spinal cord astrocytoma and paraneoplastic limbic encephalitis.

Y. Toyama, Shigeaki Suzuki, N. Suzuki, 2012, Internal medicine.

Statin Intolerance Clinical Guide 2018

S. Yamashita, T. Nakayama, H. Saito, 2020, Journal of atherosclerosis and thrombosis.

Temporal Profile and Cellular Localization of Interleukin-6 Protein after Focal Cerebral Ischemia in Rats

E. Nagata, Kortaro Tanaka, Y. Fukuuchi, 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils

E. Nagata, Kortaro Tanaka, Y. Fukuuchi, 1999, Neuroscience Letters.

Clinical and immunological differences between early and late-onset myasthenia gravis in Japan

Shigeaki Suzuki, N. Suzuki, M. Kuwana, 2011, Journal of Neuroimmunology.

Ambivalent Aspects of Interleukin-6 in Cerebral Ischemia: Inflammatory versus Neurotrophic Aspects

Kortaro Tanaka, Shigeaki Suzuki, N. Suzuki, 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Activation of Cytokine Signaling through Leukemia Inhibitory Factor Receptor (LIFR)/gp130 Attenuates Ischemic Brain Injury in Rats

Kortaro Tanaka, H. Okano, K. Sawamoto, 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Immunohistochemical Detection of Leukemia Inhibitory Factor After Focal Cerebral Ischemia in Rats

Kortaro Tanaka, Y. Fukuuchi, A. Kosakai, 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Enhanced Expression of Iba1, Ionized Calcium-Binding Adapter Molecule 1, After Transient Focal Cerebral Ischemia In Rat Brain

Kortaro Tanaka, Y. Fukuuchi, D. Ito, 2001, Stroke.

A clinical predictive score for postoperative myasthenic crisis

N. Hattori, I. Yoshino, Shigeaki Suzuki, 2017, Annals of neurology.

Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies

I. Nishino, Shigeaki Suzuki, N. Suzuki, 2015, Medicine.

Japan MG registry: Chronological surveys over 10 years

Shigeaki Suzuki, A. Uzawa, M. Takahashi, 2022, Clinical and Experimental Neuroimmunology.

Oral corticosteroid therapy and present disease status in myasthenia gravis

K. Fujihara, Shigeaki Suzuki, N. Suzuki, 2015, Muscle & nerve.

Inflammatory myopathy associated with PD-1 inhibitors.

T. Shiina, I. Nishino, Shigeaki Suzuki, 2019, Journal of autoimmunity.

Early Electromyographic Findings in Asymptomatic Siblings with McArdle’s Disease

Kortaro Tanaka, Y. Fukuuchi, S. Nogawa, 2002, European Neurology.

Myelitis associated with human herpes virus 6 (HHV-6) after allogeneic cord blood transplantation

R. Yamazaki, Y. Ikeda, Shigeaki Suzuki, 2007, Scandinavian journal of infectious diseases.

Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis

N. Hattori, T. Hatano, K. Kitagawa, 2020, Therapeutic advances in neurological disorders.

Roles of cytokines and T cells in the pathogenesis of myasthenia gravis

Shigeaki Suzuki, A. Uzawa, S. Kuwabara, 2020, Clinical and experimental immunology.

Surgical treatment for medically refractory myasthenic blepharoptosis

T. Nagasao, K. Kishi, Shigeaki Suzuki, 2014, Clinical Ophthalmology.

Surgical treatment of severe blepharoptosis and facial palsy caused by oculopharyngodistal myopathy.

T. Nagasao, K. Kishi, Shigeaki Suzuki, 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Quality of life in purely ocular myasthenia in Japan

Shigeaki Suzuki, N. Suzuki, M. Motomura, 2014, BMC Neurology.

Is Surgical Intervention Safe and Effective in the Treatment of Myasthenic Blepharoptosis? A Multicenter Survey in Japan

T. Nagasao, K. Kishi, Shigeaki Suzuki, 2014, European Neurology.

The MG‐QOL15 Japanese version: Validation and associations with clinical factors

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2012, Muscle & nerve.

Topical naphazoline in the treatment of myasthenic blepharoptosis

Y. Shimizu, Shigeaki Suzuki, N. Suzuki, 2011, Muscle & nerve.

HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis

T. Shiina, I. Nishino, Shigeaki Suzuki, 2020, PloS one.

[New clinical entity of myasthenia gravis with autoimmune targets of heart and skeletal muscles].

Shigeaki Suzuki, 2012, Rinsho shinkeigaku = Clinical neurology.

Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectomy

Kortaro Tanaka, Y. Fukuuchi, S. Nogawa, 2003, Clinical Neurology and Neurosurgery.

Tonsillectomy Improved Therapeutic Response in Anti-SRP Myopathy With Chronic Tonsillitis

I. Nishino, Shigeaki Suzuki, F. Tanaka, 2020, Frontiers in Immunology.

Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2014, Clinical Neurology and Neurosurgery.

Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer

E. Nagata, Shigeaki Suzuki, K. Murata, 2017, Internal medicine.

Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor.

Shigeaki Suzuki, S. Imai, Satoru Mitsuboshi, 2022, European journal of cancer.

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis

Shigeaki Suzuki, Y. Ando, J. Nakahara, 2019, Scientific Reports.

Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors

Shigeaki Suzuki, T. Komori, M. Seki, 2019, Journal of Immunotherapy for Cancer.

Immune-mediated Neuropathy with Anti-disialosyl IgM Antibodies in Diffuse Large B-cell Lymphoma: A Case Report and Literature Review.

S. Kusunoki, Shigeaki Suzuki, N. Suzuki, 2015, Internal medicine.

Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis

Shigeaki Suzuki, N. Suzuki, K. Iwasa, 2011, Journal of Neuroimmunology.

Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis

Shigeaki Suzuki, N. Suzuki, M. Kohno, 2013, Journal of Neuroimmunology.

Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance

Shigeaki Suzuki, K. Utsugisawa, H. Murai, 2021, Therapeutic advances in neurological disorders.

Significance of follow‐up thoracic imaging in myasthenia gravis

Shigeaki Suzuki, M. Motomura, K. Utsugisawa, 2018, Clinical and Experimental Neuroimmunology.

Three Types of Striational Antibodies in Myasthenia Gravis

Shigeaki Suzuki, N. Suzuki, K. Utsugisawa, 2011, Autoimmune diseases.

Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective

Shigeaki Suzuki, A. Uzawa, H. Murai, 2022, Expert review of clinical immunology.

Early Aggressive Treatment Strategy against Myasthenia Gravis

Shigeaki Suzuki, N. Suzuki, K. Utsugisawa, 2010, European Neurology.

Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy

I. Nishino, Shigeaki Suzuki, H. Yaguchi, 2019, Internal medicine.

Eculizumab improved weakness and taste disorder in thymoma-associated generalized myasthenia gravis with anti-striational antibodies: A case report

Shigeaki Suzuki, A. Machida, E. Amano, 2019, eNeurologicalSci.

[Recurrent syncope due to sick sinus syndrome in a patient with myasthenia gravis associated with thymoma].

Shigeaki Suzuki, Tatsuo Yamada, Y. Tsuboi, 2011, Rinsho shinkeigaku = Clinical neurology.

[A patient with giant cell myocarditis and myositis associated with thymoma and myasthenia gravis].

Y. Okada, Y. Fukuuchi, S. Nogawa, 2003, Rinsho shinkeigaku = Clinical neurology.

Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis

F. Shibasaki, K. Shigemoto, Shigeaki Suzuki, 2022, Experimental Neurology.

Chronic Myopathy Associated With Anti–Signal Recognition Particle Antibodies Can Be Misdiagnosed As Facioscapulohumeral Muscular Dystrophy

M. Sonoo, Y. Hayashi, I. Nishino, 2016, Journal of clinical neuromuscular disease.

Persistent CREB Phosphorylation with Protection of Hippocampal CA1 Pyramidal Neurons Following Temporary Occlusion of the Middle Cerebral Artery in the Rat

E. Nagata, Kortaro Tanaka, Y. Fukuuchi, 2000, Experimental Neurology.

Immunohistochemical analysis of cyclic AMP response element binding protein phosphorylation in focal cerebral ischemia in rats

E. Nagata, Kortaro Tanaka, Y. Fukuuchi, 1999, Brain Research.

Treatment of myasthenia gravis patients with calcineurin inhibitors in Japan: A retrospective analysis of outcomes

Shigeaki Suzuki, M. Motomura, K. Utsugisawa, 2015 .

Muscle pathology of antisynthetase syndrome according to antibody subtypes

N. Okiyama, M. Fujimoto, I. Nishino, 2022, medRxiv.

Author update: Sarcoplasmic MxA expression: A valuable marker of dermatomyositis

I. Nishino, Shigeaki Suzuki, A. Uruha, 2017, Neurology.

Dysautonomia associated with immune checkpoint inhibitors

Shigeaki Suzuki, J. Nakahara, T. Takizawa, 2023, Journal of Neurology.

Phosphorylation of Cyclic Adenosine Monophosphate Response Element Binding Protein in Oligodendrocytes in the Corpus Callosum after Focal Cerebral Ischemia in the Rat

Kortaro Tanaka, Y. Fukuuchi, A. Kosakai, 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain

Kortaro Tanaka, Y. Fukuuchi, A. Kosakai, 2001, Neuroreport.

Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: Analysis of 1‐year postmarketing surveillance

Shigeaki Suzuki, K. Utsugisawa, H. Murai, 2022, Clinical and Experimental Neuroimmunology.

Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis

Shigeaki Suzuki, A. Uzawa, S. Kuwabara, 2023, Journal of Neurology, Neurosurgery, and Psychiatry.

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Denny J. Padgett, Adam L. Comer, Yi-Chung Lee, 2023, The Lancet Neurology.

Targeted molecular therapy for myasthenia gravis

Shigeaki Suzuki, 2021, The Lancet Neurology.

Shigeaki Suzuki, A. Uzawa, K. Utsugisawa, 2020, Clinical and Experimental Neuroimmunology.

Rationale for the clinical guidelines for myasthenia gravis in Japan

Shigeaki Suzuki, M. Motomura, K. Utsugisawa, 2018, Annals of the New York Academy of Sciences.

[The MG-QOL15 Japanese version: validation and associations with clinical factors].

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2012, Rinsho shinkeigaku = Clinical neurology.

Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2011, BMJ Open.

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Adam L. Comer, Robert G. Miller, S. Demeret, 2023, The Lancet Neurology.

The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome

Shigeaki Suzuki, A. Uzawa, M. Motomura, 2023, Clinical and Experimental Neuroimmunology.

Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis

Shigeaki Suzuki, A. Uzawa, S. Kuwabara, 2023, Neurotherapeutics.

Insights into the Classification of Myasthenia Gravis

K. Fujihara, Shigeaki Suzuki, Takuhiro Yamaguchi, 2014, PloS one.

Japan MG Registry Study : A Sophisticated Multi-center Study of Myasthenia Gravis

J. Kira, Shigeaki Suzuki, M. Motomura, 2015 .

[Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids].

Shigeaki Suzuki, N. Suzuki, K. Utsugisawa, 2012, Rinsho shinkeigaku = Clinical neurology.

Up-regulation of the Ire1-mediated signaling molecule, Bip, in ischemic rat brain

Kortaro Tanaka, Y. Fukuuchi, A. Kosakai, 2001, Neuroreport.

Treatment experience of Taiwanese patients with anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase myopathy

I. Nishino, Hsiu-Fen Lin, W. Liang, 2020, The Kaohsiung journal of medical sciences.

Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble

T. Shiina, I. Nishino, Shigeaki Suzuki, 2019, Neuromuscular Disorders.

Immune-mediated necrotizing myopathy in a multi-ethnic malaysian cohort

I. Nishino, Shigeaki Suzuki, N. Shahrizaila, 2021 .

Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies

Y. Hayashi, I. Nishino, T. Yonekawa, 2014, Journal of Neuroimmunology.

Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy.

Shigeaki Suzuki, C. Ishida, T. Matsumura, 2017, Rinsho shinkeigaku = Clinical neurology.

Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study.

I. Nishino, Shigeaki Suzuki, Yuji Takahashi, 2017, Rinsho shinkeigaku = Clinical neurology.

HLA-DRB1 alleles in immune-mediated necrotizing myopathy

T. Shiina, I. Nishino, Shigeaki Suzuki, 2016, Neurology.

Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain

Shigeaki Suzuki, Kortaro Tanaka, A. Kosakai, 2003, Brain Research.

Inflammatory myopathy with anti-Golgi antibody and anti-SS-A/Ro antibody.

E. Nagata, H. Hattori, Shigeaki Suzuki, 2007, Internal medicine.

[Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].

Shigeaki Suzuki, 2011, Brain and nerve = Shinkei kenkyu no shinpo.

Association of immune‐mediated necrotizing myopathy with HLA polymorphisms

T. Shiina, I. Nishino, Shigeaki Suzuki, 2022, HLA.

[Non-motor symptoms in myasthenia gravis: attributed to T-cell clones from thymoma].

Shigeaki Suzuki, 2013, Brain and nerve = Shinkei kenkyu no shinpo.

GVHD-like erythroderma in the clinical course of thymoma-associated myasthenia gravis

Shigeaki Suzuki, N. Suzuki, M. Amagai, 2017, European Journal of Dermatology.

Metronidazole‐induced encephalopathy and myoclonus: Case report and a review of the literature

Shigeaki Suzuki, N. Suzuki, M. Shinoda, 2015 .

Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis

F. Shibasaki, K. Shigemoto, Shigeaki Suzuki, 2022, Experimental Neurology.

[Lambert-Eaton myasthenic syndrome (LEMS)].

Shigeaki Suzuki, 2010, Brain and nerve = Shinkei kenkyu no shinpo.

[Limbic encephalitis up to date].

Shigeaki Suzuki, N. Suzuki, M. Seki, 2011, Nihon rinsho. Japanese journal of clinical medicine.

q-Space Myelin Map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: A preliminary study

H. Okano, M. Jinzaki, J. Hata, 2017, Journal of the Neurological Sciences.

Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies: reply

Shigeaki Suzuki, N. Suzuki, M. Kuwana, 2008 .

Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1.

I. Nishino, Shigeaki Suzuki, N. Suzuki, 2016, Brain : a journal of neurology.

When do we judge IVIg for myasthenia gravis ineffective?

Shigeaki Suzuki, N. Suzuki, T. Takizawa, 2015, Neurological Sciences.

Anaphylactoid reaction to immunoadsorptive membrane in a patient with myasthenia gravis

Shigeaki Suzuki, N. Suzuki, M. Hayashi, 2012, CEN Case Reports.

Flare of myasthenia gravis induced by COVID-19 vaccines

Shigeaki Suzuki, J. Nakahara, T. Takizawa, 2022, Journal of the Neurological Sciences.

[Anti-NMDAR encephalopathy: treatment].

Shigeaki Suzuki, N. Suzuki, M. Seki, 2008, Rinsho shinkeigaku = Clinical neurology.

Two-year changes of bone mineral density in steroid-treated myasthenia gravis

Shigeaki Suzuki, 2021, Journal of Bone and Mineral Metabolism.

Causal background factors for depressive state in myasthenia gravis patients: a multicenter cooperative study

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2011 .

Alteration of Cyclic Adenosine Monophosphate Binding in Ischemic Brain: Sensitive Metabolic Marker for Early Ischemic Tissue Damage

E. Nagata, Y. Fukuuchi, Shigeaki Suzuki, 1999 .

Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis

J. Dalmau, Shigeaki Suzuki, S. Suzuki, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Alternative to steroid therapy for myasthenia gravis and myositis occurring as immune‐related adverse events

Shigeaki Suzuki, K. Iijima, M. Sugawara, 2019, Clinical and Experimental Neuroimmunology.

Uncoupling of cerebral blood flow and glucose utilization in the regenerating facial nucleus after axotomy

E. Nagata, Kortaro Tanaka, Y. Fukuuchi, 1999, Neuroscience Research.

Expression of interleukin‐6 is suppressed by inhibition of voltage‐sensitive Na+/Ca2+ channels after cerebral ischemia

Kortaro Tanaka, Y. Fukuuchi, A. Kosakai, 2000, Neuroreport.

[Oral immunotherapy].

Shigeaki Suzuki, 2015, Nihon rinsho. Japanese journal of clinical medicine.

Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1.

I. Nishino, Shigeaki Suzuki, N. Suzuki, 2016, Brain : a journal of neurology.

Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.

Y. Hayashi, I. Nishino, Shigeaki Suzuki, 2012, Archives of neurology.

Antigen‐specific T‐cell activation in hyperplastic thymus in myasthenia gravis

Shigeaki Suzuki, K. Utsugisawa, Y. Nagane, 2007, Muscle & nerve.

This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.

Shigeaki Suzuki, Atsuko Nishikawa, Hiroaki Nishimura, 2015 .

Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan

Shigeaki Suzuki, A. Uzawa, K. Utsugisawa, 2023, Journal of Neuroimmunology.

Adult phenylketonuria presenting with subacute severe neurologic symptoms

Shigeaki Suzuki, H. Shibata, T. Takizawa, 2015, Journal of Clinical Neuroscience.

A case of atypical inflammatory myositis with hypergammaglobulinemic purpura

Shigeaki Suzuki, N. Suzuki, Kentaro Ohara, 2016, Journal of the Neurological Sciences.

免疫介在性壊死性ミオパチー（IMNM）とHLA多型

Shigeaki Suzuki, S. Suzuki, A. Shigenari, 2017 .

Enzyme‐linked immunosorbent assays for diagnosis of immune‐mediated necrotizing myopathy

I. Nishino, Shigeaki Suzuki, N. Suzuki, 2016 .